Day 2 of #ESCCongress has wrapped!
#ACCPresident @drroxmehran.bsky.social details some of the top trials from day two in Munich, including highlights from Hotline 3 such as LIBREXIA ACS and aspirin omission studies.
🔗 More coverage: https://bit.ly/4gAFan1
Day 2 of #ESCCongress has wrapped! #ACCPresident @drroxmehran.bsky.social details some of the top trials from day two in Munich, including highlights from Hotline 3 such as LIBREXIA ACS and aspirin omission studies. 🔗 More coverage: https://bit.ly/4gAFan1
0 vue
Publié le 29/08/2026 16:17
Day 2 of #ESCCongress has wrapped!
#ACCPresident @drroxmehran.bsky.social details some of the top trials from day two in Munich, including highlights from Hotline 3 such as LIBREXIA ACS and aspirin omission studies.
🔗 More coverage: https://bit.ly/4gAFan1
0 commentaire
?